Literature DB >> 17566676

Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics.

Susumu Nagayama1, Ken-ichi Ogawara, Yoshiko Fukuoka, Kazutaka Higaki, Toshikiro Kimura.   

Abstract

The relationship between the time-dependent change in serum proteins adsorbed on nanoparticles and their disposition to the liver was investigated by employing lecithin-coated polystyrene nanosphere with a size of 50 nm (LNS-50) as a model nanoparticle in rats. The total amount of proteins adsorbed on LNS-50 increased and the qualitative profile of serum proteins adsorbed on LNS-50 changed during the incubation with serum up to 360 min. The liver perfusion study indicated that the hepatic uptake of LNS-50 incubated with serum for 360 min was significantly larger than those of LNS-50 incubated for shorter period. It was suggested that the increase in the hepatic uptake of LNS-50 with the increase in incubation time would be ascribed mainly to the increase in the opsonin-mediated uptake by Kupffer cells. Semi-quantification of major opsonins, complement C3 (C3) and immunoglobulin G (IgG), and in vitro uptake study in primary cultured Kupffer cells demonstrated that the increase in C3 and IgG amounts adsorbed on LNS-50 was directly reflected in the increased disposition of LNS-50 to Kupffer cells. These results indicate that the amounts of opsonins associated on nanoparticles would change over time and this process would be substantially reflected in the alteration of their hepatic disposition characteristics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17566676     DOI: 10.1016/j.ijpharm.2007.04.036

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  43 in total

1.  Spherical nucleic acid nanoparticle conjugates enhance G-quadruplex formation and increase serum protein interactions.

Authors:  Alyssa B Chinen; Chenxia M Guan; Chad A Mirkin
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-13       Impact factor: 15.336

Review 2.  Analytical strategies for detecting nanoparticle-protein interactions.

Authors:  Liwen Li; Qingxin Mu; Bin Zhang; Bing Yan
Journal:  Analyst       Date:  2010-05-26       Impact factor: 4.616

Review 3.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

4.  The Impact of Protein Corona Formation on the Macrophage Cellular Uptake and Biodistribution of Spherical Nucleic Acids.

Authors:  Alyssa B Chinen; Chenxia M Guan; Caroline H Ko; Chad A Mirkin
Journal:  Small       Date:  2017-02-14       Impact factor: 13.281

Review 5.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

Authors:  Marina A Dobrovolskaia; Parag Aggarwal; Jennifer B Hall; Scott E McNeil
Journal:  Mol Pharm       Date:  2008-05-30       Impact factor: 4.939

Review 6.  Direct Drug Targeting into Intracellular Compartments: Issues, Limitations, and Future Outlook.

Authors:  Gamaleldin I Harisa; Tarek M Faris
Journal:  J Membr Biol       Date:  2019-08-02       Impact factor: 1.843

7.  Protein Interactions with Nanoparticle Surfaces: Highlighting Solution NMR Techniques.

Authors:  Y Randika Perera; Rebecca A Hill; Nicholas C Fitzkee
Journal:  Isr J Chem       Date:  2019-09-19       Impact factor: 3.333

8.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

Authors:  Rajiv Kumar; Indrajit Roy; Tymish Y Ohulchanskky; Lisa A Vathy; Earl J Bergey; Munawwar Sajjad; Paras N Prasad
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

Review 9.  Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Authors:  Frank Alexis; Eric Pridgen; Linda K Molnar; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2008-08-04       Impact factor: 4.939

10.  Biodistribution Analysis of NIR-Labeled Nanogels Using in Vivo FMT Imaging in Triple Negative Human Mammary Carcinoma Models.

Authors:  Mallory R Gordon; Jiaming Zhuang; Judy Ventura; Longyu Li; Kishore Raghupathi; S Thayumanavan
Journal:  Mol Pharm       Date:  2018-02-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.